Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

These 2 cases demonstrate a tragic complication of natalizumab therapy in this promising novel immune modulatory therapy, and the difficulties of predicting late stage drug failures in the difficult and costly process of drug development.

PML Complicating Treatment with Natalizumab (Tysabri) for MS